DUBLIN--(BUSINESS WIRE)--The "Atherectomy Devices Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis" report has been ...
DelveInsight's Peripheral Vascular Devices Market Insights report provides the current and forecast market analysis, individual leading peripheral vascular devices companies' market shares, challenges ...
Becton, Dickinson and Company BDX, also popularly known as BD, recently received 510(k) clearance for expanded indications from the FDA for the Rotarex Atherectomy System. It is important to mention ...
REDWOOD CITY, Calif., March 29, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that Arne ...
Routine use of an orbital atherectomy device to remove calcium from severely blocked coronary arteries before patients undergo cardiac stenting procedures does not improve outcomes, a Mount Sinai-led ...
CARLSBAD, Calif.--(BUSINESS WIRE)-- Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on developing its excimer laser system to treat vascular diseases, announces ...
Please provide your email address to receive an email when new articles are posted on . The FDA has cleared a 225 cm radial access catheter for PAD atherectomy. Radial access may reduce bleeding risk ...
New York, Nov. 26, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Spain Atherectomy Devices Market Outlook to 2025 - Coronary Atherectomy Devices and Lower Extremity ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardio Flow, Inc., a privately held medical device company and developer of minimally invasive devices to treat peripheral artery disease (PAD), today announced it ...
ALBANY, New York, June 20, 2019 /PRNewswire/ -- Growing acceptance for minimally invasive procedures coupled with rising patient's pool for the people need to undergo surgeries is creating need for ...
Cardiovascular Systems Inc. (CSI) reported the submission by its partner Innova Vascular Inc. of U.S. FDA premarket notification for thrombectomy devices to treat peripheral vascular disease. Already ...